Company Quick10K Filing
Neuroone Medical Technologies
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 13 $46
10-Q 2020-02-14 Quarter: 2019-12-31
10-K 2019-12-20 Annual: 2019-09-30
S-1 2019-07-15 Public Filing
10-Q 2019-08-14 Quarter: 2019-06-30
10-Q 2019-05-10 Quarter: 2019-03-31
S-1 2019-02-11 Public Filing
10-Q 2019-02-14 Quarter: 2018-12-31
10-K 2018-12-12 Annual: 2018-09-30
S-1 2018-09-10 Public Filing
10-Q 2018-08-13 Quarter: 2018-06-30
10-Q 2018-05-16 Quarter: 2018-03-31
10-K 2018-04-16 Annual: 2017-12-31
10-Q 2017-11-14 Quarter: 2017-09-30
10-Q 2017-08-14 Quarter: 2017-06-30
10-Q 2017-05-22 Quarter: 2017-03-31
10-K 2017-04-17 Annual: 2016-12-31
10-Q 2016-11-21 Quarter: 2016-09-30
10-Q 2016-08-19 Quarter: 2016-06-30
10-Q 2016-05-23 Quarter: 2016-03-31
10-K 2016-04-14 Annual: 2015-12-31
10-Q 2015-11-16 Quarter: 2015-09-30
10-Q 2015-08-13 Quarter: 2015-06-30
10-Q 2015-05-20 Quarter: 2015-03-31
10-K 2015-04-15 Annual: 2014-12-31
10-Q 2014-11-19 Quarter: 2014-09-30
10-Q 2014-08-18 Quarter: 2014-06-30
10-Q 2014-05-20 Quarter: 2014-03-31
10-K 2014-04-15 Annual: 2013-12-31
10-Q 2013-11-15 Quarter: 2013-09-30
10-Q 2013-08-15 Quarter: 2013-06-30
10-Q 2013-05-15 Quarter: 2013-03-31
10-K 2013-04-11 Annual: 2012-12-31
10-Q 2012-11-13 Quarter: 2012-09-30
10-Q 2012-08-15 Quarter: 2012-06-30
10-Q 2012-05-15 Quarter: 2012-03-31
10-K 2012-03-28 Annual: 2011-12-31
10-Q 2011-11-07 Quarter: 2011-09-30
10-Q 2011-08-22 Quarter: 2011-06-30
8-K 2020-02-18 Sale of Shares, Officers, Exhibits
8-K 2020-01-21 Enter Agreement, Sale of Shares, Exhibits
8-K 2019-12-31 Officers
8-K 2019-12-05 Enter Agreement, Exhibits
8-K 2019-12-03 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2019-12-02 Other Events, Exhibits
8-K 2019-11-01 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2019-10-23 Enter Agreement, Sale of Shares, Exhibits
8-K 2019-10-21 Enter Agreement
8-K 2019-10-07 Enter Agreement, Exhibits
8-K 2019-09-18 Enter Agreement, Regulation FD, Exhibits
8-K 2019-08-14 Earnings, Exhibits
8-K 2019-07-30 Officers
8-K 2019-06-28 Enter Agreement, Sale of Shares, Exhibits
8-K 2019-06-11 Enter Agreement, Sale of Shares, Exhibits
8-K 2019-06-04 Shareholder Vote
8-K 2019-03-29 Enter Agreement, Sale of Shares, Exhibits
8-K 2019-02-28 Enter Agreement, Leave Agreement, Sale of Shares, Exhibits
8-K 2019-01-29 Officers
8-K 2018-12-31 Enter Agreement, Exhibits
8-K 2018-12-28 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-12-12 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2018-11-30 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-11-20 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2018-10-26 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-09-27 Regulation FD, Other Events, Exhibits
8-K 2018-09-25 Enter Agreement, Sale of Shares, Amend Bylaw, Exhibits
8-K 2018-09-07 Enter Agreement, Sale of Shares
8-K 2018-08-24 Other Events, Exhibits
8-K 2018-08-03 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-07-17 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-07-09 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-07-02 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-06-05 Shareholder Vote
8-K 2018-05-30 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2018-05-17 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2018-05-08 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2018-04-26 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2018-04-13 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-04-06 Amendment
8-K 2018-03-20 Enter Agreement, Off-BS Arrangement, Other Events
8-K 2018-03-12 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-03-01 Enter Agreement
8-K 2018-02-13 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-01-25 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-01-17 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-01-02 Enter Agreement, Sale of Shares, Exhibits

Neuroone Medical Technologies Financials

NMTC Metrics, Comps, Filings

Annual | Quarterly

Business

Corporate Overview of NeuroOne Medical Technologies Corporation

We were originally incorporated as Original Source Entertainment, Inc. under the laws of the State of Nevada on August 20, 2009. Prior to the closing of the Acquisition, as defined below, we completed a series of steps contemplated by a Plan of Conversion pursuant to which we, among other things, changed our name to NeuroOne Medical Technologies Corporation, increased our authorized number of shares of Common Stock from 45,000,000 to 100,000,000, increased our authorized number of shares of preferred stock from 5,000,000 to 10,000,000 and reincorporated in Delaware. On July 20, 2017, we acquired NeuroOne, Inc. (the “Acquisition”). Immediately following the closing of the Acquisition, the business of NeuroOne, Inc. became our sole focus. Unless otherwise stated or unless the context otherwise requires, the description of our business set forth below is provided on a combined basis, taking into account our wholly-owned subsidiary, NeuroOne, Inc.

NeuroOne, Inc. was incorporated under the laws of the State of Delaware on October 7, 2016. Its predecessor entity, NeuroOne LLC (the “LLC”), was formed on December 13, 2013 and operated as a limited liability company until it was merged with and into NeuroOne, Inc. on October 27, 2016 with NeuroOne, Inc. as the surviving entity (the “Merger”). As a result of the Merger, all of the properties, rights, privileges and powers of the LLC vested in NeuroOne, Inc., and all debts, liabilities and duties of the LLC became the debts, liabilities and duties of NeuroOne, Inc., except for the license agreement (the “WARF License”) with the WARF which was not legally transferred until May 2017. The purposes of the Merger were to: change the jurisdiction of incorporation from Minnesota to Delaware; change the ownership of the LLC's underlying assets; and convert from a limited liability company to a corporation.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Annual)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
GB Sciences (GBLX) 48,125 5% -3.6 -59% 30,023 12,867 3,433 187 -17,677 -13,391 48,419
Cosmos Holdings (COSM) 47,675 7% 14.4 10% 21,830 26,614 39,156 2,591 2,233 3,453 49,707
IEH Corporation (IEHC) 47,580 28% 5.1 20% 27,676 4,489 26,931 7,491 5,593 8,100 41,135
Intelgenx Technologies (IGXT) 46,764 0% -4.1 -67% 15,811 10,393 1,964 0 -10,635 -10,337 42,188
Ipsidy (IDTY) 46,631 76% -5.3 -51% 18,341 4,513 2,871 2,177 -9,358 -8,373 44,462
Neuroone Medical Technologies (NMTC) 45,755 -5.8 -497% 1,536 1,809 0 0 -7,640 -7,634 44,508
Netlist (NLST) 45,497 8% -3.3 -94% 17,711 29,791 26,841 2,123 -16,599 -16,386 53,262
School Specialty (SCOO) 45,313 33% 65.3 -15% 333,360 297,493 661,434 219,132 -50,912 3,515 229,477
PayMeOn (PAYM) 45,288 -588% -6.5 -210% 3,305 3,481 7 -39 -6,943 -6,828 44,360
Smith Midland (SMID) 45,184 34% 10.3 5% 39,498 19,868 30,585 10,467 2,021 4,474 46,011
Mobivity Holdings (MFON) 45,078 54% -6.4 -128% 6,651 10,078 11,348 6,167 -8,523 -7,625 48,940
Haha Generation (HAHA) 45,023 -772.2 -181% 32 300 0 0 -58 -58 44,992
Hickok (HICKA) 44,979 22% 4.7 10% 63,062 46,527 87,257 18,968 6,422 11,382 53,975
Positive Physicians Holdings (PPHI) 44,543 0% -33.1 -0% 156,562 84,131 13,239 0 -469 -609 20,177
Intersections (INTX) 44,437 68% 4.2 25% 37,736 36,881 155,171 105,871 9,357 13,535 56,883
Petroshare (PRHR) 44,347 0% 13.2 -54% 36,928 45,101 24,631 0 -19,790 3,086 40,589
Barfresh (BRFH) 44,229 53% -9.4 -90% 7,289 4,942 4,743 2,519 -6,591 -4,804 45,225
Morphic Holding (MORF) 44,192 0% 0.0 -5% 178,610 104,779 5,567 0 -9,433 -9,298 -282
Gulfslope Energy (GSPE) 43,691 -2.6 -49% 37,551 37,142 0 0 -18,233 -15,841 41,391
Solis Tek (SLTK) 43,541 26% -5.0 -491% 1,802 7,207 2,271 582 -8,858 -8,719 43,301

Balance Sheet ($'000)2011-12-312012-12-312014-12-312015-12-312016-12-312017-12-312018-06-302018-09-302019-03-31
Cash1410202623132,305
Accounts Receivable00
Inventory
PP&E
Assets1410242502302192,575
Accounts Payable10172282221688
Long-Term Debt411,6251,7911,3940
Liabilities171836831185,2877,5184,6152,130
Stockholders' Equity-3-17-35-81-114-5,037-7,289-4,396445
Income Statement ($'000)2011-12-312012-12-312014-12-312015-12-312016-12-312017-12-312018-06-302018-09-302019-03-31
Revenue51110
Cost of Revenue20
Gross Profit31
R&D
SG&A3115375033
Tax00000
Net Income-28-14-36-63-48
Cash Flow ($'000)2011-12-312012-12-312014-12-312015-12-312016-12-312017-12-312018-06-302018-09-302019-03-31
Cash Operating27-14-26-45-21
Cash Investing00000
Cash Financing321264721